Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125686341 | 12568634 | 1 | I | 20160712 | 20160719 | 20160719 | EXP | CA-AMGEN-CANSP2016090585 | AMGEN | 29.00 | YR | A | F | Y | 0.00000 | 20160718 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125686341 | 12568634 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | U | 103795 | UNKNOWN FORMULATION | ||||||||
| 125686341 | 12568634 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 125686341 | 12568634 | 3 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | UNK | 0 | ||||||||||
| 125686341 | 12568634 | 4 | SS | NEORAL | CYCLOSPORINE | 1 | Unknown | UNK | 0 | ||||||||||
| 125686341 | 12568634 | 5 | SS | REMICADE | INFLIXIMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 125686341 | 12568634 | 6 | SS | SECUKINUMAB | SECUKINUMAB | 1 | Subcutaneous | 300 MG, QMO | 0 | 300 | MG | INJECTION | /month | ||||||
| 125686341 | 12568634 | 7 | SS | SECUKINUMAB | SECUKINUMAB | 1 | Unknown | 150 MG, UNK | 0 | 150 | MG | INJECTION | |||||||
| 125686341 | 12568634 | 8 | SS | STELARA | USTEKINUMAB | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125686341 | 12568634 | 1 | Product used for unknown indication |
| 125686341 | 12568634 | 2 | Product used for unknown indication |
| 125686341 | 12568634 | 3 | Product used for unknown indication |
| 125686341 | 12568634 | 4 | Psoriasis |
| 125686341 | 12568634 | 5 | Product used for unknown indication |
| 125686341 | 12568634 | 6 | Psoriasis |
| 125686341 | 12568634 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125686341 | 12568634 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125686341 | 12568634 | Drug ineffective | |
| 125686341 | 12568634 | Dysphonia | |
| 125686341 | 12568634 | Genital cyst | |
| 125686341 | 12568634 | Lymphadenopathy | |
| 125686341 | 12568634 | Nasopharyngitis | |
| 125686341 | 12568634 | Oral candidiasis | |
| 125686341 | 12568634 | Oropharyngeal pain | |
| 125686341 | 12568634 | Pain | |
| 125686341 | 12568634 | Psoriasis | |
| 125686341 | 12568634 | Secretion discharge | |
| 125686341 | 12568634 | Sinusitis | |
| 125686341 | 12568634 | Sneezing | |
| 125686341 | 12568634 | Streptococcal infection | |
| 125686341 | 12568634 | Tongue discolouration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |